has been cited by the following article(s):
|
[1]
|
Innovative immunotherapy targeting at PD-1/PD-L1 signaling pathway: mechanism, efficacy and safety analysis of monotherapy and combination therapies in non-small cell lung cancer (NSCLC) treatment
E3S Web of Conferences,
2021
DOI:10.1051/e3sconf/202126702026
|
|
|
|